BLACK WEEKSViales −15% · kits −10% · resto −5%con el códigoEnvío gratis en Alemania a partir de 200 €

Esta página se ha traducido automáticamente y puede contener errores. ¿Eres hablante nativo? Nos encantaría recibir tus comentarios y correcciones.Enviar comentarios

The Peptide Desk The Peptide Desk
Cabergoline, foto del producto
PCT & AI

Cabergoline

PCT & AI

  • Envío desde Alemania

Pedido

Precio unitario - Envío gratis en Alemania a partir de 200 € durante las Black Weeks
  • DHL con seguimiento
  • Embalaje discreto

4.6 de 5 en Trustpilot73 reseñas

También buscado como: Cabergolin

De un vistazo

Cabergoline en cifras

Las cifras clave de nuestra enciclopedia. Arrastra el punto a lo largo de la curva para ver cuánto queda tras una dosis, según el cálculo.

Entrada completa de la enciclopedia

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~2.9 days

Half-life ~2.9 days
After 5.8 days: 25 %
Day 2.950 %Day 5.825 %Day 8.812.4 %Day 14.63.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about70hours

Class
Dopamine D2 receptor agonist
Use
Oral1-2x per week
Sizes
0.25 to 0.5 mg2 sizes in the shop

Todavía no hay ningún análisis de laboratorio de Cabergoline. Vota por élHazlo analizar tú mismo, pagamos la mitadTodos los análisis de laboratorio

Conocimiento

Todo sobre Cabergoline

Información detallada próximamente.

Dosificación

Cargando información de dosificación …

Más en la enciclopedia

FAQ

Preguntas frecuentes

Fuentes de cada respuesta: entrada de la enciclopedia

¿Aún tienes alguna pregunta?

Escríbenos, nuestro equipo te ayudará.

How does cabergoline lower prolactin?

Cabergoline binds as an agonist to the dopamine D2 receptor. Dopamine is the natural brake on the prolactin cells in the pituitary. According to the label it has only low affinity for other receptors such as D1, alpha adrenoceptors and serotonin receptors.

Is cabergoline approved?

Yes. ChEMBL lists cabergoline as an approved compound with first approval in 1996. On ClinicalTrials.gov 83 trials list cabergoline (as of 26 October 2026). Everything here is the state of research, not a recommendation.

Is it better than bromocriptine?

In the large comparison trial with 459 women yes: prolactin was stably normal in 83 instead of 59 percent, 72 instead of 52 percent ovulated or became pregnant. Side effects occurred in 68 instead of 78 percent, 3 instead of 12 percent stopped. A French trial with 120 women came to the same result.

What about the heart valves?

The label requires a heart ultrasound before starting and checks every 6 to 12 months. Valve changes occurred mostly at high doses in Parkinson's treatment, but there are also cases at lower doses. In a cohort study in Parkinson's the rate was 68 per 10,000 person-years, with other drugs 10 to 11.

Why dizziness on standing?

Cabergoline can lower blood pressure, especially when standing up quickly. In the placebo-controlled trial 15 percent had dizziness and 4 percent a drop in blood pressure on standing, 5 and 0 percent on placebo. The label advises checking blood pressure at the start and during use.

Can cabergoline affect behaviour?

Yes, the label lists impulse control disorders: new or stronger urges to gamble, increased sexual urges, uncontrolled spending and binge eating. Anyone noticing this should raise it with a doctor.

Which trials are running right now?

As of 26 October 2026 recruiting trials include a phase 3 trial with 382 planned participants against bromocriptine, a phase 3 trial on the safety of a higher dose in microprolactinomas and a phase 4 trial on metabolism in prolactinomas.

Relacionados

Productos relacionados